The University of Bristol has been ranked fifth in the UK and tenth in Europe for life sciences and deep tech spinouts, according to an inaugural report published by Dealroom.co – the global data platform for intelligence on startups, innovation, high-growth companies, ecosystems and investment strategies.
A consortium of seven institutions led by the University of Bristol, has received a grant of £2.7m to undertake ground-breaking research into manufacturing new materials which have the ability to self-heal or regenerate.
A University of Bristol project aiming to develop next-generation therapeutics for autoimmune diseases has received over £850,000 in new funding through the beLAB1407 BRIDGE partnership, supported by Evotec and its global pharmaceutical collaborators.
University of Bristol biotech spin-out company Cirrus Therapeutics has today [2 October] announced the close of an £8 million seed financing to advance its pipeline of gene and cell therapies aimed at improving the quality of life for patients with chronic blinding diseases.
The University of Bristol will contribute to a new research hub to increase global immunisation coverage and improve response to viral outbreaks through the rapid and cost-effective deployment of vaccines.
Dr David Tew, Director, Advanced Manufacturing Technology and GSK Senior Fellow at GlaxoSmithKline, will join the University of Bristol as a Royal Society Entrepreneur in Residence from September 2018.
Hundreds of talented scientists and engineers are set to advance solutions for some of the world’s most pressing challenges, ranging from reaching net-zero and developing sustainable energy to improving digital security and making the latest health breakthroughs.
The University of Bristol’s BioDesign Institute hosted the Synthetic & Engineering Biology British-Swiss Summit on 22 May 2024. The inaugural event was devoted to understanding the opportunities presented by engineering biology technologies to drive innovation in healthcare, forging collaborations between Switzerland and the UK with a focus on environmental sustainability.
A new initiative to increase the visibility of the South West’s growing life sciences ecosystem has been launched.
New technology to develop red blood cells that carry additional proteins within them to provide therapeutic benefit which can reach all parts of the body, has received funding to progress the innovation.
